This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Szinnai, G. Articles by Polak, M. Search for Related Content PubMed PubMed Citation Articles by Szinnai, G. Articles by Polak, M. Related Collections Thyroid

Extending the Clinical Heterogeneity of Iodide Transport Defect (ITD): A Novel Mutation R124H of the Sodium/Iodide Symporter Gene and Review of Genotype-Phenotype Correlations in ITD

Pediatric Endocrine Unit, and Institut National de la Santé et de la Recherche Médicale, Equipe mixte INSERM 0363, Hôpital Necker Enfants-Malades (G.S., M.P.), 75743 Paris, France; Departments of Clinical Genetics and Medical Ethics, Kyoto University Graduate School of Medicine (S.K.), Kyoto 606-8501, Japan; Department of Endocrinology and Diabetes, Molecular Laboratory, Centre Hospitalier Universitaire (C.D., V.D.), 35043 Rennes, France; and Pediatric Endocrine and Diabetes Unit, Hôpital Robert Debré (N.L., P.C.), 75019 Paris, France

Address all correspondence and requests for reprints to: Dr. Michel Polak, Service d’Endocrinologie Pédiatrique and Institut National de la Santé et de la Recherche Médicale, Equipe Mixte INSERM 0363, Hôpital Necker Enfants Malades, 149 rue de Sèvres, F-75743 Paris Cedex 15, France. E-mail: michel.polak{at}nck.ap-hop-paris.fr.

Context: Iodide transport defect (ITD) is an autosomal recessive disorder resulting in varying degrees of congenital hypothyroidism (CH) with goiter and low or absent radioiodide uptake (RIUT), as determined by thyroid scintigraphy, and low iodide saliva to plasma ratio. Defects of the sodium/iodide symporter gene (NIS) have been shown to cause ITD.

Objective: We describe molecular studies of NIS in a patient with ITD and genotype-phenotype correlation analysis in 31 patients with NIS defects reported worldwide.

Design: NIS sequencing and functional studies of the new NIS mutation in vitro were performed.

Results: In a newborn with symptomatic CH and a large goiter, thyroid scintigraphy showed no RIUT (0%). NIS sequencing identified the new homozygous mutation, R124H, in exon 2. This mutation was associated with abolition of iodide uptake in vitro when transfected in COS-7 cells. Immunocytochemical studies documented correct targeting of the mutated protein to the plasma membrane of transfected cells. Genotype-phenotype correlation analysis showed that the onset of hypothyroidism occurred during the neonatal period with four NIS mutations (neonatal onset of hypothyroidism genotype), during infancy with three NIS mutations (infancy onset of hypothyroidism genotype), and during childhood with three NIS mutations (childhood onset of hypothyroidism genotype). RIUT is a direct measure of residual NIS activity in vivo. Mean RIUT was lower in patients with the neonatal onset of hypothyroidism genotype (0.88 ± 0.2%) than in the infancy onset of hypothyroidism (1.9 ± 0.4%; P < 0.05) and childhood onset of hypothyroidism (2.6 ± 0.7%; P < 0.05) genotypes.

Conclusions: We identified a new NIS mutation, R124H, in a newborn with the complete clinical ITD phenotype. Genotype-phenotype correlations suggest that age at hypothyroidism onset may be genotype specific and may depend on genotype-specific residual NIS activity.

This article has been cited by other articles:

				M. D. Reed-Tsur, A. De la Vieja, C. S. Ginter, and N. Carrasco Molecular Characterization of V59E NIS, a Na+/I- Symporter Mutant that Causes Congenital I- Transport Defect Endocrinology, June 1, 2008; 149(6): 3077 - 3084. [Abstract] [Full Text] [PDF]

				M. Dayem, C. Basquin, V. Navarro, P. Carrier, R. Marsault, P. Chang, S. Huc, E. Darrouzet, S. Lindenthal, and T. Pourcher Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization J. Endocrinol., April 1, 2008; 197(1): 95 - 109. [Abstract] [Full Text] [PDF]

				G. Szinnai, L. Lacroix, A. Carre, F. Guimiot, M. Talbot, J. Martinovic, A.-L. Delezoide, M. Vekemans, S. Michiels, B. Caillou, et al. Sodium/Iodide Symporter (NIS) Gene Expression Is the Limiting Step for the Onset of Thyroid Function in the Human Fetus J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 70 - 76. [Abstract] [Full Text] [PDF]